OBJECTIVE

2

To provide reference for primary medical institutions to carry out homogeneous oncology pharmacy service.

METHODS

2

The model and procedure of homogeneous oncology pharmacy outpatient service were established in the medical alliances. The practice data of oncology pharmacy outpatient service were retrospectively analyzed， and preliminary analysis and evaluation were conducted for the effects of pharmacy service.

RESULTS

2

During more than one year of the practice of the model， a total of 123 patients （170 case times） were served in the oncology pharmacy department； 83 case times of potential drug interaction were screened for 59 patients； 78 patients were intervened with adverse reactions and combined symptoms by pharmacists，of which 65.4% of patients’ adverse reaction grades and combined symptoms improved after intervention by pharmacists； 419 case times were followed up by telephone or WeChat

including 294 case times were educated on medication； 97.6% of patients understood and adopted medication education，87.1% of patients had good medication compliance； 55 case times （32.3%） of pharmacist intervention and medication adjustment were accepted by patients； 95.1% of the patients were very satisfied with oncology pharmacy outpatient service.

CONCLUSIONS

2

To construct a homogeneous tumor pharmacy outpatient service model in the medical alliances

can provide professional rational drug use guidance and scientific medication regulation for patients， and also can help the quality of medical alliance oncology pharmacy services to achieve homogeneous development.